Categories Multiple Myeloma

Xpovio Approved in Israel for Some Myeloma, Lymphoma Patients

Xpovio Approved in Israel for Some Myeloma, Lymphoma Patients The Israeli Ministry of Health has approved Xpovio (selinexor), in combination with the corticosteroid dexamethasone, for the treatment of people with multiple myeloma who have received three or more prior therapies, and who failed to respond to at least one immunomodulatory agent, one proteasome inhibitor, and […]

Read More
Categories Multiple Myeloma

FDA Clears Way for Clinical Trial of HDP-101

FDA Clears Way for Clinical Trial of HDP-101 Heidelberg Pharma has been cleared in the U.S. to begin a clinical trial testing its investigational therapy HDP-101 for the treatment of multiple myeloma. The U.S. Food and Drug Administration (FDA) allowed the start of a Phase 1/2a trial following the submission of an investigational new drug […]

Read More
Categories Multiple Myeloma

2018 Treatment Algorithm for Multiple Myeloma

2018 Treatment Algorithm for Multiple Myeloma Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions 2018 Treatment Algorithm for Multiple Myeloma Presented by S. Vincent Rajkumar, MD Friday, December 8, 2017 Atlanta, Georgia Friday Satellite Symposium preceding the 59th ASH Annual Meeting & Exposition. This activity is supported by educational grants from […]

Read More
Categories Multiple Myeloma

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the …

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the … Corresponding Author Multiple Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Correspondence: Dickran Kazandjian, M.D., Multiple Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, […]

Read More
Categories Multiple Myeloma

Global Biologic Market Size, Share, Value, and Competitive Landscape 2021

Global Biologic Market Size, Share, Value, and Competitive Landscape 2021 Global biologic market is expected to grow at a CAGR of 8.6% during forecasted period 2017-2023 and reach till $425 million by end of 2023. Biologics are the drugs prepare or obtain from the biological organism. They are composed of protein, sugars or nucleic acids. […]

Read More
Categories Multiple Myeloma

Dexamethasone Market Globally Expected to Drive Growth through 2031

Dexamethasone Market Globally Expected to Drive Growth through 2031 Dexamethasone is corticosteroid drug used to treat many conditions like skin disease, rheumatic disease, lung disease, bowel disorders and certain cancers. Dexamethasone is an anti-inflammatory drug and hence reduces symptoms like allergy and swelling. It also has properties like immunosuppression and can penetrate into the brain. […]

Read More
Categories Multiple Myeloma

Hem/Onc Roundup: Cancer is the Leading Cause of Death Among Patients with Diabetes in the …

Hem/Onc Roundup: Cancer is the Leading Cause of Death Among Patients with Diabetes in the … This week on DocWire News, editors spoke with Dr. Raj Chakraborty, assistant professor of medicine at Columbia University Irving Medical Center, about promising research on bispecific T-cell engagers (BiTEs) for treatment of multiple myeloma, and things to consider when […]

Read More